Month: September 2016

Business Cocktail

The Business Cocktail

Bayer AG and Evotec AG enter a multi-target research partnership agreement Bayer and Evotec have agreed to develop novel treatments for...

Read More

Merck Focuses its Research on Hard to Treat Cancers

Snippets

Merck is a leading science and technology company, and has many projects that are involved in research to find treatments for diseases that...

Read More

Notizia

Notizia

Read More

Cervical Cancer: Current Scenario

Articles

Cervical cancer is the second most common cause of death in women globally. Increased awareness and early diagnosis has reduced the death...

Read More

FDA Approves Sarepta’s Muscular Dystrophy Drug after Months of Debate

Snippets

The Food and Drug Administration approved the recent controversial drug to treat Duchenne muscular Dystrophy, which is a rare disease that...

Read More

PI3Kγ- a molecular switch that controls immune suppression

Snippets

Macrophages play critical role in acute and chronic inflammation and cancer. In response to pathogens or injury, inflammatory macrophages...

Read More

Graft vs. Host Disease

Articles

It is a well-known fact that where there is stem cell transplantation, there is Graft vs Host Disease (GVHD). The concept arose 2 decades...

Read More
Close